Concepedia

Michael W. Nagle

MW

22

Publications

3K

Citations

18

H-Index

1997

Active since

Affiliations

Pfizer (United States)(Current)

Boston University

Massachusetts General Hospital

Washington University in St. Louis

Eisai (United States)

Michael W. Nagle is an author at Pfizer (United States) specializing in medicine, genetics, and genetic epidemiology.

ORCID

Top concepts

Publications per year

1997–2025

22

Publications

22

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Craig Hyde, Michael W. Nagle, Chao Tian et al. · Nature Genetics · 2016 · 827 citations · Full text

, , +10

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Lasse Folkersen, Stefan Gustafsson, Qin Wang et al. · Nature Metabolism · 2020 · 740 citations · Full text

, , +9

A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study

Jemma B. Wilk, Ting-hsu Chen, Daniel J. Gottlieb et al. · PLoS Genetics · 2009 · 350 citations · Full text

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease

Christopher D. Whelan, Niklas Mattsson, Michael W. Nagle et al. · Acta Neuropathologica Communications · 2019 · 266 citations · Full text

Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells

Jan R. Kraehling, John H. Chidlow, Chitra Rajagopal et al. · Nature Communications · 2016 · 151 citations · Full text

Rows per page

1–5 of 22